%0 Journal Article
%T Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
%A Daisuke Nobuoka
%A Itaru Endo
%A Junji Furuse
%A Katsuhiko Uesaka
%A Kazuya Ofuji
%A Kenji Yamao
%A Kohei Nakachi
%A Mari Takahashi
%A Masafumi Ikeda
%A Masaru Konishi
%A Mayuko Yoshimura
%A Naoto Gotohda
%A Naoya Yamazaki
%A Nobuhiro Tsuchiya
%A Shinichiro Takahashi
%A Shoichi Mizuno
%A Tadatoshi Takayama
%A Taira Kinoshita
%A Tetsuya Nakatsura
%A Toshiaki Yoshikawa
%A Yu Sawada
%A Yuichiro Kato
%J Archive of "Oncoimmunology".
%D 2016
%R 10.1080/2162402X.2015.1129483
%K Adjuvant therapy
%K CTL
%K glypican-3
%K HCC
%K peptide vaccine
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910752/